Aktienkurs
228.22
Täglich Wechseln
0.43 0.19%
Monatlich
-5.88%
Jährlich
46.00%
Q2 Prognose
222.63




Lieferungen Und Leistungen Veränderung Datum
AbbVie USD 12.59B 180M 2025-12
Abbott USD 10.57B 171M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Baxter International USD 2.01B 231M 2025-12
Bayer EUR 14.19B 720M 2025-12
Becton, Dickinson and Co. USD 2.51B 486M 2025-12
Biogen USD 1.87B 17M 2025-12
Boston Scientific USD 2.93B 98M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
CONMED USD 247.83M 22.89M 2025-12
Cooper Companies USD 807.1M 21.9M 2025-12
Dexcom USD 1.28B 167.3M 2025-12
Edwards Lifesciences USD 912.1M 19.3M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Globus Medical USD 743.66M 55.54M 2025-12
Insulet USD 516.9M 54.7M 2025-12
Integra LifeSciences USD 278.85M 16.69M 2025-12
Intuitive Surgical USD 1.6B 68.3M 2026-03
J&J USD 21.33B 3.72B 2025-12
Medtronic USD 6.36B 30M 2025-12
Merck USD 12.12B 596M 2025-09
Merit Medical Systems USD 223.61M 7.9M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
Stryker USD 4.04B 396M 2025-12
Tandem Diabetes Care USD 165.49M 39.55M 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Zimmer Biomet Holdings USD 1.73B 24.2M 2026-03
Zoetis USD 1.59B 49M 2025-12